Disease Domain | Count |
---|---|
Immune System Diseases | 1 |
Infectious Diseases | 1 |
Top 5 Drug Type | Count |
---|---|
Immunoglobulin | 1 |
Mesenchymal stem cell therapy | 1 |
Target- |
Mechanism Stem cell replacements |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication- |
Drug Highest PhasePhase 2 |
First Approval Ctry. / Loc.- |
First Approval Date- |
Target- |
Mechanism- |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication- |
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date- |
Start Date01 Oct 2025 |
Sponsor / Collaborator [+1] |
Start Date14 May 2025 |
Sponsor / Collaborator |
Start Date07 Apr 2025 |
Sponsor / Collaborator |
Drug(Targets) | Indications | Global Highest Phase |
---|---|---|
Mesenchymal Stem Cell(University of Liege) | Crohn Disease More | Phase 2 |
CMV-Ig | Cytomegalovirus Infections More | Preclinical |